Snowball logo
logo
ALXN_logo

Alexion Pharmaceuticals, Inc

ALXN β€’ NASDAQ Delisted
-- $$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20162017201820192020TTM
Revenue
Total revenue
3,0843,551.14,131.24,991.16,069.96,261.6
COGS
258454.2374.3394.5553.5567.2
Gross Profit
2,8263,096.93,756.94,596.65,516.45,694.4
Operating Expenses & Income
Operating Income
7938041,594.62,139.92,859.92,947.2
Total Operating Expenses
2,0332,292.92,162.32,456.72,656.52,747.2
R&D Expenses
757878.4730.48861,002.91,091.1
Selling General & Admin Expenses
9541,094.41,111.81,261.11,399.91,432.1
Earnings from Continuing Operations
Interest Expense
-----(106)
Interest Income
8679.932.922.5--
Income Tax Expense
177104.5164.6(225.5)(34.4)(27)
Net Income
Net Income
399443.377.62,404.3603.4681.8
Supplemental
EBIT
673646.2340.42,256.6673.7760.8
EBITDA
995966.3660.52,566.2927.41,076.5
In millions of USD, except % and values per 1 share